UBS analyst Peter Grom lowered the firm's price target on Scotts Miracle-Gro to $63 from $70 and keeps a Neutral rating on the shares. Ahead of a conference presentation, Scotts Miracle-Gro faces concerns around slower demand, unfavorable weather, consumer weakness, and rising input costs, which have pressured the stock, the analyst tells investors in a research note. While management remains committed to offsetting higher costs through pricing and achieving margin expansion, organic sales growth and gross margin improvement are increasingly likely to land near the lower end of guidance, though current FY26 targets still appear attainable, the firm says.
